4//SEC Filing
Fowler John Franklin 4
Accession 0001415889-25-004308
CIK 0001645666other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:53 PM ET
Size
5.5 KB
Accession
0001415889-25-004308
Insider Transaction Report
Form 4
Fowler John Franklin
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-14+5,000→ 5,000 totalExercise: $5.89Exp: 2035-02-13→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]One-hundred percent (100%) of the shares subject to the option shall vest on February 1, 2026, subject to Reporting Person continuing to provide service through such date.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001744263
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:53 PM ET
- Size
- 5.5 KB